Collagen shot shows promise for blood sugar control

NCT ID NCT07149064

Recruiting now Disease control Sponsor: Rousselot BVBA Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a daily collagen supplement called Nextida GC-B can improve blood sugar control in adults with normal blood sugar or prediabetes. Over 90 days, researchers will measure how the body handles sugar after meals and track changes in HbA1c. Sixty participants will receive either the supplement or a placebo to see if there is a real benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: collagen hydrolysate (Nextida GC-B)
What this could lead to: If it works, this could point toward a simple dietary supplement to help manage blood sugar spikes in people with prediabetes.
What could go wrong: This is a small, early-stage trial with only 60 participants, so results may not apply widely. The supplement is tested against a placebo, and the effect on long-term diabetes prevention is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLYCEMIC CONTROL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLYCEMIC CONTROL NORMOGLYCEMIA PREDIABETES

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

KGK Science Inc.
RECRUITING

London, Ontario, N6B3L1, Canada

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.